About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT02781623

Quantifying Quadriceps Atrophy Following Tibial Plateau Fracture

This study will quantify and examine the extent to which the quadriceps femoris muscle group atrophies following tibial plateau fractures and the length of time that atrophy affects function. The stud...

Lead sponsor: NYU Langone Health•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

NYU Langone Health

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•All racial and ethnic groups
•Diagnosis of tibial plateau fracture
•Patients who opt for surgical treatment or non-operative treatment of their fracture
•Patients who consent to undergoing 3 MRI scans
•Patients who are willing to follow-up for a minimum of 52 weeks

Exclusion Criteria

•Patients younger than 18 years old or older than 65
•Patients who may be pregnant or may become pregnant in the 52 weeks following injury
•Patients who have electric, magnetic, or mechanical devices currently implanted
•Patients who have abnormal ECG results
•Diagnosis of any additional lower extremity fractures other than tibial plateau
•Patients who fit the definition of a vulnerable population

Related studies

RECRUITINGPhase 2

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

NCT06990269 · Geographic Atrophy Secondary to Age-related Macular Degeneration

Clinical Procedures to Support Research in ALS

NCT03489278 · Amyotrophic Lateral Sclerosis, ALS-Frontotemporal Dementia, and more

Prospective Multicenter Registry Study of Multiple System Atrophy in China

NCT07644013 · Multiple System Atrophy, Parkinson's Disease, and more

RECRUITINGPhase 2

Proof of Concept Study of Vaginal AZU-101 in Vulvovaginal Atrophy in Postmenopausal Women

NCT06197568 · Vulvo Vaginal Atrophy (VVA)

RECRUITINGPhase 2

An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy

NCT07197866 · Multiple System Atrophy

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 16, 2022Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment13

Start dateOct 2015

Last updatedNov 16, 2022

Condition

Locations shown

New York University Langone Medical Center

New York, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 16, 2022Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions